MARINUS PHARMACEUTICALS, INC.·4

Jan 30, 4:30 PM ET

Shafer Christina 4

4 · MARINUS PHARMACEUTICALS, INC. · Filed Jan 30, 2023

Insider Transaction Report

Form 4
Period: 2023-01-26
Shafer Christina
CHIEF COMMERCIAL OFFICER
Transactions
  • Award

    Common Stock

    2023-01-26+17,37543,022 total
  • Award

    Stock Option (Right to Buy)

    2023-01-26+78,18878,188 total
    Exercise: $5.94Exp: 2033-01-26Common Stock (78,188 underlying)
Footnotes (2)
  • [F1]Represents the grant of restricted stock units (RSUs). The RSUs vest in three equal installments, with the first installment vesting on February 15, 2024, the second installment vesting on February 15, 2025, and the third installment vesting on February 15, 2026, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer.
  • [F2]The option vests and becomes exercisable in 36 equal monthly installments beginning on February 26, 2023, subject to the reporting person's continued service with the Issuer.

Documents

1 file
  • 4
    form4-01302023_090106.xmlPrimary